Anavex Life Sciences Corp (AVXL)

[Doc328]

Is it possible that hypertension measurements were a data point Anavex collected in the P2b/3 but did not disclose it?

We know a lot of data has not yet been disclosed. Most notably the ADCS-ADL means.

Vital signs have been taken at every physical visit for all studies I've ever been part of --- therefore, Anavex should have this data on 500-600 adults for various time points. However, many of these patients would have started with normal BP so the hypertension at entry n would be low - hence the AD trial can give a hint of efficacy but would be insufficient to prove it. A separate hypertension study would need to be performed. On the positive side these are usually far shorter and less expensive per person than a CNS trial